Home » Insmed Selling Boulder Facility to Merck
Insmed Selling Boulder Facility to Merck
February 13, 2009
Insmed Inc. is selling its division focused on developing generic biotechnology drugs to pharmaceutical giant Merck for $130 million, the company announced.
Denver Business Journal
Denver Business Journal
Upcoming Events
-
21Oct